Author:
Eyles Darryl W.,Stedman Terry J.,Pond Susan M.
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Altamura C, Mauri, M, Cavallaro R, Colacurico F, Gorni A, Bareggi S (1988) Reduced haloperidol/haloperidol ratio and clinical outcome in schizophrenia: preliminary evidence. Prog Neuropsychopharmacol Biol Psychiatry 12:689–694
2. Bareggi SR, Mauri M, Cavallaro R, Regazzetti MG, Moro AR (1990) Factors affecting the clinical response to haloperidol therapy is schizophrenia. Clin Neuropharmacol 13 [Suppl. 1]:S29-S34
3. Behm HL, Wagner (1979) JG Errors in interpretation of data from equilibrium dialysis protein binding experiments. Res Commun Chem Path Pharmacol 26: 145–160
4. Browning JL, Harrington CA, Davis CM (1985) Quantification of reduced haloperidol and haloperidol by radioimmunoassay. J. Immunoassay 6:45–66
5. Chang WH, Lin SK, MW Jann, YWF Lam, TY Chen, CT Chen, WH Hu, EK Yeh (1989) Pharmacodynamics and pharmacokinetics of haloperidol and reduced haloperidol in schizophrenic patients. Biol Psychiatry 26:239–249
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献